Long-term dual antiplatelet therapy and bleeding in stable patients—insights from CHARISMA

被引：1
|
作者：
Joana Osório
机构：
来源：
Nature Reviews Cardiology | 2010年 / 7卷 / 9期
关键词：
D O I：
10.1038/nrcardio.2010.114
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：478 / 478
相关论文
共 50 条
  • [31] Platelet ADP reactivity and bleeding risk in long-term double antiplatelet therapy patients with coronary artery disease
    Guskova, E.
    Komarov, A.
    Dobrovolsky, A.
    Deev, A.
    Samko, A.
    Panchenko, E.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 881 - 881
  • [32] Dual antiplatelet therapy in stable patients with coronary artery disease: determinants and impact on prognosis, insights from the coronor
    Lemesle, G.
    Lamblin, N.
    Meurice, T.
    Tricot, O.
    Lallemant, R.
    Nugue, O.
    Delomez, M.
    Equine, O.
    Tondeux, S.
    Bauters, C.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 : 904 - 904
  • [33] Dual Antiplatelet Therapy Cessation due to Bleeding Complication is Related to Long-Term Clinical Outcome Following Percutaneous Coronary Intervention
    Tanaka, Shigemitsu
    Ikari, Yuji
    Komai, Taichi
    Ijichi, Takeshi
    Yanagiswa, Katsuaki
    Kamiyama, Yoshinari
    Nakazawa, Gaku
    Masuda, Naoki
    Matsukage, Takashi
    Ogata, Nobuhiko
    Morino, Yoshihiro
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (13) : B26 - B27
  • [34] Bleeding complications in diabetic patients treated with long-term (5 years) dual antiplatelet treatment following DES implantation; comparison to patients on single antiplatelet treatment
    Karyofyllis, P.
    Doulaptsis, C.
    Moukas, I.
    Thomopoulou, S.
    Voudris, V.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 : 549 - 549
  • [35] Predicting long-term bleeding risk after acute coronary syndrome: a step closer to optimising dual antiplatelet therapy duration?
    Wilson, Simon
    Newby, David E.
    [J]. HEART, 2017, 103 (15) : 1143 - 1145
  • [36] The Relationship of Platelet Function Measurements with Bleeding Outcomes During Long-term Treatment with Dual Antiplatelet Therapy in Medically Managed NSTE-ACS Patients
    Cornel, Jan H.
    Ohman, E. M.
    Neely, Benjamin
    Jakubowski, Joseph A.
    Bhatt, Deepak L.
    White, Harvey D.
    Ardissino, Diego
    Fox, Keith A.
    Prabhakaran, Dorairaj
    Armstrong, Paul W.
    Erlinge, David
    Gurbel, Paul A.
    Roe, Matthew T.
    [J]. CIRCULATION, 2014, 130
  • [37] Long-term therapy for uremic bleeding
    Sloand, JA
    [J]. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1996, 19 (08): : 439 - 440
  • [38] Minor bleeding in CHD patients receiving dual antiplatelet therapy
    Sumarokov, A. B.
    Buryachkovskaya, L., I
    Uchitel, I. A.
    Shirokova, T. E.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 584 - 584
  • [39] Challenges of long-term dual antiplatelet therapy use following acute coronary syndromes
    Sidhu, Mandeep S.
    Lyubarova, Radmila
    Bangalore, Sripal
    Bonaca, Marc P.
    [J]. AMERICAN HEART JOURNAL, 2022, 246 : 44 - 64
  • [40] Impact of Platelet Reactivity on Long-term Clinical Outcomes and Bleeding Events in Japanese Patients Receiving Antiplatelet Therapy with Aspirin
    Yamane, Keiichiro
    Ikeda, Tomoyuki
    Taniguchi, Ryoji
    Watanabe, Shin
    Kawato, Mitsunori
    Kondo, Hirokazu
    Shirakawa, Ryutaro
    Higashi, Tomohito
    Toma, Masanao
    Tabuchi, Arata
    Tamura, Toshihiro
    Takahashi, Kanako
    Watanabe, Haruyo
    Yoshikawa, Yuka
    Kita, Toru
    Kimura, Takeshi
    Horiuchi, Hisanori
    [J]. JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2012, 19 (12) : 1142 - 1153
12345